目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T32008 | |||
GSK299423 (GlaxoSmithKline 299423) is an antibiotic that may have therapeutic effect in patients infected with bacteria expressing New Delhi metal-β-lactamase. Antibiotics inhibit the topoisomerases that the bacteria need to replicate. | |||
T13395L | Antibacterial | ||
Zidebactam (WCK-5107) 是一种β-内酰胺酶抑制剂。它也是一种青霉素结合蛋白 2 抑制剂,IC50值为 0.26 μg/ml。 | |||
T23801 | Antibacterial | ||
WCK-4234 sodium (WCK 4234) 是一种 β-内酰胺酶抑制剂,可用于针对 MDR 感染的研究。 WCK-4234 sodium 抑制 A、C 和 D 类 β-内酰胺酶和 OXA 碳青霉烯酶。 | |||
T13038 | Antibacterial Antibiotic | ||
Sultamicillin 是一种具有口服活性的氨苄西林/舒巴坦双前药。它是一种半合成 β-内酰胺酶抑制剂。 | |||
T17210L | Antibacterial | ||
Vaborbactam ammonium salt 是一种 β-内酰胺酶抑制剂,可以恢复碳青霉烯类药物对 KPC 生产菌株的活性,常与其它药物连用来研究真菌感染。 | |||
T12166 | Antibacterial | ||
Nacubactam (OP0595 free acid) 是一种非 β-内酰胺-β-内酰胺酶抑制剂,对 A 类和 C 类 β-内酰胺酶具有活性。它作为青霉素结合蛋白 2 活性抗菌剂,并赋予 β-内酰胺酶非依赖性增强作用以靶向其他 PBP。 | |||
T1143 | Cell wall Antibacterial Antibiotic | ||
Carbenicillin disodium (BRL-2064) 作用于细菌细胞壁合成的最后阶段,是β-内酰胺青霉素衍生物。 | |||
T0234 | Antibacterial Antibiotic | ||
Methicillin sodium salt 是β-内酰胺抗生素,抑制参与肽聚糖合成的青霉素结合蛋白。 | |||
T23858 | Antibacterial | ||
WCK-5153 是 β-Lactamase 的增强剂和 PBP2 的抑制剂,对铜绿假单胞菌具有抗菌活性。 WCK-5153 可用于治疗由高度耐药的革兰氏阴性病原体引起的严重感染的研究。 | |||
T13077 | Antibacterial Antifungal | ||
Taniborbactam dihydrochloride (VNRX-5133 dihydrochloride) 是一种具有选择性和有效性的新型环硼酸β-内酰胺酶抑制剂,具有抗菌活性,对革兰氏阴性菌抑制作用显著。Taniborbactam dihydrochloride 抑制 KPC-2,AmpC,OXA-48 和 VIM-2 ,可以用于研究真菌感染。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPJ-01157 | LACTB2 Protein, Human, Recombinant (GST) | Human | E. coli | ||
β-Lactamase-like Protein 2 (LACTB2) is a number of the metallo-beta-lactamase superfamily.LACTB2 also belongs to the Glyoxalase II family. LACTB2 is 288 amino acids long with 8 zinc-binding domains. The LACTB2 gene is expressed at high levels and annotates structural defects or features in 4 cDNA clones. LACTB2 proteins are expected to have hydrolase activity and metal ion-binding functions. LACTB2 protein is found to localize in mitochondrion. Other functions of LACTB2 is yet unknown.
|
|||||
TMPH-03165 | Beta-lactamase Protein, Pseudomonas aeruginosa, Recombinant (His & SUMO) | Pseudomonas aeruginosa | E. coli | ||
Beta-lactamase Protein, Pseudomonas aeruginosa, Recombinant (His & SUMO) is expressed in E. coli with N-terminal 6xHis-SUMO tag. The predicted molecular weight is 56.7 kDa. Accession number: P24735
|
|||||
TMPH-00588 | Beta-lactamase Protein, E. coli, Recombinant (His & SUMO) | E. coli | E. coli | ||
This protein is a serine beta-lactamase with a substrate specificity for cephalosporins.
|
|||||
TMPH-00586 | Beta-lactamase TEM Protein, E. coli, Recombinant (His) | E. coli | Yeast | ||
TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins. TEM-3 and TEM-4 are capable of hydrolyzing cefotaxime and ceftazidime. TEM-5 is capable of hydrolyzing ceftazidime. TEM-6 is capable of hydrolyzing ceftazidime and aztreonam. TEM-8/CAZ-2, TEM-16/CAZ-7 and TEM-24/CAZ-6 are markedly active against ceftazidime. IRT-4 shows resistance to beta-lactamase inhibitors.
|
|||||
TMPH-00587 | Beta-lactamase TEM Protein, E. coli, Recombinant (His & SUMO) | E. coli | E. coli | ||
TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins. TEM-3 and TEM-4 are capable of hydrolyzing cefotaxime and ceftazidime. TEM-5 is capable of hydrolyzing ceftazidime. TEM-6 is capable of hydrolyzing ceftazidime and aztreonam. TEM-8/CAZ-2, TEM-16/CAZ-7 and TEM-24/CAZ-6 are markedly active against ceftazidime. IRT-4 shows resistance to beta-lactamase inhibitors.
|
|||||
TMPH-02373 | Metallo-beta-lactamase type 2 Protein, Klebsiella pneumoniae, Recombinant (His) | Klebsiella pneumoniae | E. coli | ||
Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring. Does not confer resistance to the polymixin colistin or the fluoroquinolone ciprofloxacin.
|
|||||
TMPH-03474 | Beta-lactamase CTX-M-2 Protein, Salmonella typhimurium, Recombinant | Salmonella typhimurium | E. coli | ||
Has cefotaxime-hydrolyzing activity.
|
|||||
TMPH-00584 | Beta-lactamase CTX-M-1 Protein, E. coli, Recombinant (His) | E. coli | E. coli | ||
Broad spectrum beta-lactamase which confers resistance to penicillins, as well as first, second and third-generation cephalosporins.
|
|||||
TMPH-03488 | Metallo-beta-lactamase type 2 Protein, Serratia marcescens, Recombinant (His & Myc) | Serratia marcescens | E. coli | ||
Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring.
|
|||||
TMPH-03164 | Beta-lactamase OXA-10 Protein, Pseudomonas aeruginosa, Recombinant (His & SUMO) | Pseudomonas aeruginosa | E. coli | ||
Hydrolyzes both carbenicillin and oxacillin.
|
|||||
TMPH-00585 | Beta-lactamase CTX-M-1 Protein, E. coli, Recombinant (Yeast, His) | E. coli | Yeast | ||
Broad spectrum beta-lactamase which confers resistance to penicillins, as well as first, second and third-generation cephalosporins.
|